Literature DB >> 16550210

Clinical implications of pharmacogenomics of statin treatment.

L M Mangravite1, C F Thorn, R M Krauss.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16550210     DOI: 10.1038/sj.tpj.6500384

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


× No keyword cloud information.
  55 in total

Review 1.  Pharmacogenetics of response to statins.

Authors:  Issam Zineh
Journal:  Curr Atheroscler Rep       Date:  2007-09       Impact factor: 5.113

2.  The Pathway Less Traveled: Moving from Candidate Genes to Candidate Pathways in the Analysis of Genome-Wide Data from Large Scale Pharmacogenetic Association Studies.

Authors:  R A Wilke; R K Mareedu; J H Moore
Journal:  Curr Pharmacogenomics Person Med       Date:  2008

3.  Should we select for genetic moral enhancement? A thought experiment using the MoralKinder (MK+) haplotype.

Authors:  Halley S Faust
Journal:  Theor Med Bioeth       Date:  2009-01-09

Review 4.  Genetics and personalized medicine--a role in statin therapy?

Authors:  Jaideep Patel; Thura Abd; Roger S Blumenthal; Khurram Nasir; H Robert Superko
Journal:  Curr Atheroscler Rep       Date:  2014-01       Impact factor: 5.113

5.  Personalised medicine in hypercholesterolaemia: the role of pharmacogenetics in statin therapy.

Authors:  Najmeh Ahangari; Mohammad Doosti; Majid Ghayour Mobarhan; Amirhossein Sahebkar; Gordon A Ferns; Alireza Pasdar
Journal:  Ann Med       Date:  2020-08-24       Impact factor: 4.709

6.  Comparative analysis of the gut microbiota in distinct statin response patients in East China.

Authors:  Baoqing Sun; Luming Li; Xinfu Zhou
Journal:  J Microbiol       Date:  2018-11-27       Impact factor: 3.422

7.  PharmGKB: an integrated resource of pharmacogenomic data and knowledge.

Authors:  Li Gong; Ryan P Owen; Winston Gor; Russ B Altman; Teri E Klein
Journal:  Curr Protoc Bioinformatics       Date:  2008-09

Review 8.  Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin.

Authors:  Pertti J Neuvonen; Janne T Backman; Mikko Niemi
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

9.  Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease.

Authors:  Julie M Zissimopoulos; Douglas Barthold; Roberta Diaz Brinton; Geoffrey Joyce
Journal:  JAMA Neurol       Date:  2017-02-01       Impact factor: 18.302

10.  The SLCO1B1*5 genetic variant is associated with statin-induced side effects.

Authors:  Deepak Voora; Svati H Shah; Ivan Spasojevic; Shazia Ali; Carol R Reed; Benjamin A Salisbury; Geoffrey S Ginsburg
Journal:  J Am Coll Cardiol       Date:  2009-10-20       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.